How to Read a Peptide Certificate of Analysis (CoA)

What Is a Peptide Certificate of Analysis?

A Certificate of Analysis (CoA) is the primary quality document provided by a peptide supplier to verify that a specific product lot meets stated quality specifications. For research peptides, the CoA is your primary — and often only — window into the actual quality of what you are purchasing. Understanding how to read and critically evaluate a CoA is one of the most important skills a peptide researcher can have.

The CoA is not a marketing document. A well-prepared CoA contains raw analytical data from laboratory instruments, lot-specific information, and method details that allow a qualified reader to independently assess whether the product meets acceptable quality standards. A poorly prepared or falsified CoA contains vague claims, recycled data, or numbers without supporting evidence.

This guide walks through every element of a peptide CoA, explains what the data means, and highlights the red flags that signal low quality, misleading documentation, or outright fraud.

Why the CoA Is Critical for Research

Before diving into the details, it is worth understanding why the CoA matters for research outcomes:

Dose accuracy depends on purity. If you weigh 1 mg of a peptide that is 95% pure, you have 0.95 mg of active compound, not 1 mg. For dose-response experiments where accuracy matters, uncorrected purity errors introduce systematic bias across all data points.

Impurities can generate artifacts. A 5% impurity fraction may contain truncated peptides, oxidized variants, or racemized residues — each potentially having different or opposite biological activity compared to the target. Without understanding what the impurities are, you cannot know whether your results reflect the target compound or a mixture.

Lot-to-lot consistency matters. If your CoA is not lot-specific but reflects a "representative" sample, you have no guarantee that your actual batch has the same quality as what was tested.

Independent verification requires documented methods. To confirm a supplier's claims, you need to know their analytical method (column, gradient, detection wavelength) so a third-party lab can replicate the analysis.

The Essential Elements of a Valid CoA

1. Product Identification

The header of a CoA should unambiguously identify the product:

•Peptide name: Full chemical name or internationally recognized name
•Peptide sequence: Full one-letter or three-letter amino acid sequence
•Molecular formula: Chemical formula, e.g., C₆₂H₉₈N₁₆O₂₂ for BPC-157
•Molecular weight (MW): Calculated theoretical molecular weight
•CAS number: Chemical Abstracts Service registry number (if assigned)
•Lot/batch number: A unique identifier for this specific production run

Red flag: No sequence listed. If the supplier provides a name but no sequence, there is no way to verify identity through mass spectrometry. Every CoA for a defined peptide should include the full sequence.

Red flag: No lot number, or a generic lot number that applies to all customers. Each production run has unique characteristics; a lot number is how you trace quality to a specific batch.

2. HPLC Purity Data

High-Performance Liquid Chromatography (HPLC) purity is the primary quantitative quality metric for research peptides. The CoA should include:

#### Purity Percentage

The purity result states what percentage of the total UV-absorbing material corresponds to the target peptide peak. For example: "Purity: 98.3% by HPLC."

Acceptable thresholds:

•≥95%: Minimum acceptable for most research
•≥98%: Recommended for dose-response, in vivo, and binding studies
•≥99%: High-grade; suitable for reference standards and sensitive assays

The number alone is not enough. The CoA must show the analytical method and ideally the actual chromatogram image.

#### HPLC Method Details

The method section should specify:

•Column: Manufacturer, model, dimensions (e.g., "Waters Atlantis C18, 4.6 × 150 mm, 3 µm")
•Mobile phase A: Typically "0.1% TFA in water" or "0.1% formic acid in water"
•Mobile phase B: Typically "0.1% TFA in acetonitrile" or "0.1% formic acid in acetonitrile"
•Gradient: Time program showing % B over time
•Flow rate: Typically 1.0 mL/min
•Detection wavelength: Most commonly 214 nm (peptide bond absorbance)
•Injection volume and sample concentration

Why method details matter: Without knowing the gradient, column, and wavelength, a third-party lab cannot reproduce the analysis. Generic methods ("standard reverse-phase HPLC") are insufficient for independent verification.

Red flag: "Purity tested by HPLC: 98%" with no method details whatsoever.

#### The Chromatogram Image

A legitimate CoA includes the actual HPLC chromatogram as an image — the recorder trace showing UV absorbance vs. time. What to look for:

Good signs:

•A dominant main peak with small or absent side peaks
•Integration table showing peak areas and percentages
•Clear x-axis (time in minutes) and y-axis (absorbance)
•Baseline that returns to near-zero between peaks

Warning signs:

•Broad, asymmetric main peak (suggests co-eluting impurities)
•Missing baseline resolution between peaks
•Multiple peaks of similar height (low purity sample)
•Compressed y-axis that obscures small peaks
•No integration data shown

Red flag: A CoA with a purity number but no chromatogram image. Reputable suppliers always provide the actual chromatogram.

Red flag: A suspiciously "perfect" chromatogram — a single perfectly symmetrical peak with absolutely no baseline noise. Real analytical data has minor imperfections.

3. Mass Spectrometry Identity Confirmation

Mass spectrometry (MS) confirms that the peptide has the correct molecular identity by measuring its molecular weight. The CoA should include:

#### Expected vs. Observed Molecular Weight

The CoA should clearly show:

•Calculated/expected MW: Theoretical molecular weight calculated from the sequence
•Observed MW: Measured from the mass spectrum
•Mass accuracy: The difference between expected and observed, typically ±0.1 Da or ±5 ppm

Example of a valid MS result:

Expected MW: 1419.53 Da
Observed MW: 1419.6 Da
[M+H]+:    1420.6
[M+2H]2+:  710.8
[M+3H]3+:  474.2

#### Understanding Charge States in ESI-MS

Electrospray ionization (ESI) — the most common ionization for peptides — produces multiply charged ions. A peptide with mass M will appear at m/z values:

•[M+H]+ = M+1.008 (singly charged)
•[M+2H]2+ = (M+2×1.008)/2 (doubly charged)
•[M+3H]3+ = (M+3×1.008)/3 (triply charged)

A CoA that shows m/z values with charge state assignments demonstrates proper MS interpretation.

Red flag: MS result that says only "MW confirmed" or "mass matches" without showing actual m/z values.

Red flag: Observed MW differs from expected MW by more than 1 Da (for average mass measurements).

Red flag: No MS data at all. Modern peptide characterization always includes MS as minimum quality confirmation.

4. Appearance Description

A physical appearance description should be provided: "White to off-white lyophilized powder" is typical for most research peptides.

Red flag: Product that arrives with appearance dramatically different from the CoA description — e.g., a yellow/brown powder when "white" was specified.

5. Additional Tests

Higher-quality suppliers may include additional testing parameters:

#### Water Content (Karl Fischer Titration)

Lyophilized peptides are hygroscopic and absorb atmospheric moisture. Water content typically ranges from 5-20% by mass. This matters for dosing accuracy: a reported 10 mg vial with 15% water actually contains approximately 8.5 mg of peptide material.

How to use this data: If water content is 12%, your 10 mg vial contains 8.8 mg peptide (10 × 0.88). Adjust your weighing accordingly for accurate dosing.

#### Peptide Content by Amino Acid Analysis (AAA)

Amino acid analysis quantifies the actual peptide fraction of the sample mass. A peptide can show 98% HPLC purity but only 70% peptide content due to high water and counterion content. For precise dosing, peptide content is more accurate than HPLC purity alone.

#### Endotoxin Testing (LAL Assay)

The Limulus Amebocyte Lysate (LAL) assay measures bacterial endotoxin contamination. Critical for in vivo research:

•Acceptable limits: < 1 EU/mg for most in vivo applications
•Stricter limits: <0.1 EU/mg for CNS or immunological research

Red flag for in vivo researchers: No endotoxin data for products intended for injection in animal models.

Reading a CoA: Step-by-Step Process

When you receive a CoA, follow this systematic evaluation:

Step 1: Verify the Lot Number Matches Your Order

The lot number on your CoA must match the lot number on your product vial. If they don't match, contact the supplier.

Step 2: Check the Molecular Weight

Calculate the expected molecular weight from the sequence and compare to the CoA's stated calculated MW. Discrepancies of more than 1-2 Da warrant investigation.

Step 3: Evaluate the MS Data

Check that the observed molecular weight matches the expected. Look at the actual m/z values if shown, and verify consistency with stated charge states.

Step 4: Assess the HPLC Purity and Chromatogram

•Is the purity ≥98% (or your threshold)?
•Is the chromatogram image included?
•Does the chromatogram show a dominant main peak with minimal impurities?
•Are method details provided?

Step 5: Look for Red Flags

Run through the red flags checklist. A single red flag warrants inquiry. Multiple red flags are grounds for seeking independent analytical verification.

Red Flag Summary

Issue	Risk Level
No lot number	High
No peptide sequence	High
No chromatogram image	High
No MS data	High
Purity stated without method	High
Observed MW differs >1 Da	High
Appears fabricated/computer-generated	Critical
Generic "representative" CoA	Medium
No method details (column, gradient)	Medium
Water content not reported	Low
No endotoxin testing (for in vivo use)	High

In-House vs. Third-Party Testing: Why It Matters

Every research peptide comes with a CoA, but who performed that testing matters enormously.

In-house testing means the supplier tested their own product. This is common, cost-effective, and not inherently dishonest — but it creates a conflict of interest. The supplier has financial motivation to report favorable results. Without independent verification, you must trust that their instruments are properly calibrated, their methods are sound, and their analysts are reporting accurately.

Third-party testing means an independent laboratory — with no financial stake in the outcome — analyzed the peptide. A third-party CoA carries far greater credibility because the lab's reputation depends on accuracy, not sales.

The gold standard for research peptide procurement is a supplier who provides both their own in-house CoA and independent third-party verification — or who routinely submits lots to external labs for confirmation.

Top Third-Party Testing Labs for Research Peptides

Several specialized analytical labs have become trusted names in the research peptide community for independent verification:

Janoshik Analytical

Janoshik (janoshik.com) is a Czech Republic-based analytical laboratory widely used by the research peptide community for independent HPLC purity and mass spectrometry testing. Key characteristics:

•Specializes in research compounds including peptides and SARMs
•Provides HPLC chromatograms, mass spectra, and full analytical reports
•Turnaround typically 1–3 weeks
•Results are often posted publicly on peptide research forums, enabling community verification
•Pricing is accessible for individual researchers (~$50–100/test)

When you see a supplier link to a Janoshik test report, you can verify it's authentic by checking the report number directly on their website.

Vanta Analytical

Vanta is another third-party lab used in research peptide quality verification, offering HPLC and MS testing with detailed reporting. Vanta reports are recognized within research communities as credible independent documentation.

Other Recognized Labs

•Simec AG (Switzerland): ISO-accredited lab offering peptide HPLC and MS testing; used by European suppliers
•SGS, Eurofins, Labcorp: Large commercial analytical networks offering peptide purity testing ($50–200/sample); widely used for higher-volume or clinical-grade testing
•University analytical facilities: Many universities have analytical chemistry cores offering HPLC and MS services to external clients
•Collaborating laboratories: A colleague can run your sample if method details are shared

How to Verify a Third-Party Test Report

A third-party report should include:

•The name and logo of the independent lab
•A unique report or batch number
•Date of analysis
•Name of the compound and lot/batch number
•Full HPLC chromatogram with integration table
•MS spectrum with m/z data
•Analyst signature or lab director sign-off

Red flag: A "third-party tested" claim with no report number, no lab name, or no way to verify the report is genuine.

What to request for independent testing:

•RP-HPLC purity on C18 column with TFA/ACN gradient
•ESI-MS molecular weight confirmation
•Endotoxin by LAL (if in vivo use planned)
•Water content by Karl Fischer (if dosing accuracy critical)

How Peptides.SO Verifies Supplier Testing

Peptides.SO has developed a structured verification framework to evaluate the quality and credibility of supplier testing documentation. Rather than simply listing suppliers, our platform assesses each supplier's CoA documentation against defined quality standards.

Our verification process evaluates:

•Test authenticity: Does the supplier provide verifiable test reports from recognized labs, or only self-produced documentation?
•Lab independence: Are third-party labs genuinely independent, with publicly verifiable results?
•Documentation completeness: Does the CoA include all essential elements — lot number, HPLC chromatogram, MS data, method details?
•Consistency across lots: Do suppliers provide consistent CoA quality across different products and batches?
•Third-party lab reputation: Are reports from labs with established community credibility (e.g., Janoshik, Vanta, Simec)?

Suppliers listed on our platform have been reviewed against these standards. Our Suppliers directory includes quality indicators and testing transparency scores for each vendor. You can review individual supplier CoA practices and community-verified test results through supplier profile pages.

For full details on our quality verification methodology, see our Standards page, which outlines the CoA requirements and testing evidence thresholds used to evaluate each supplier.

What to Do When a CoA Fails Your Evaluation

Mild concern (e.g., method details incomplete): Contact supplier and request the missing information. Legitimate suppliers should be able to provide it.

Significant concern (e.g., MS mass doesn't match, no chromatogram): Do not use the product in critical experiments until independent verification is obtained.

Serious concern (e.g., multiple red flags, data appears fabricated): Do not use the product. Consider reporting to review platforms including Peptides.SO.

Missing critical data for in vivo use: Request testing from a certified laboratory before use, or source from a different supplier.

Building a CoA Archive

For reproducible research, maintain a CoA archive:

•Download digital CoAs and organize by peptide/lot
•Record lot numbers in your laboratory notebook for every experiment
•Keep CoAs for at least 5 years or duration of the study
•Note any discrepancies between CoA and actual product received

This archive is essential if research is published and questions arise about reagent quality.

Comparing CoA Quality Across Suppliers

When choosing between suppliers for the same peptide, compare their CoAs directly:

Tier 1 — Full documentation:

•Lot-specific HPLC with chromatogram + method details
•MS confirmation with m/z data
•Water content or amino acid analysis
•Endotoxin testing
•Appearance and storage conditions

Tier 2 — Adequate documentation:

•Lot-specific HPLC with chromatogram
•MS confirmation with observed MW
•Purity ≥98%

Tier 3 — Minimal documentation (acceptable only for exploratory work):

•HPLC purity number with chromatogram
•MS confirmation (may lack m/z detail)

Not acceptable (for any research):

•HPLC purity number without chromatogram
•No MS data
•Generic or non-lot-specific CoA

When building supplier relationships, consistently request Tier 1 documentation. Suppliers who invest in thorough analytical documentation generally invest similarly in manufacturing quality.

Summary

The Certificate of Analysis is your primary quality assurance tool for research peptides. A valid CoA must include: lot-specific information, peptide sequence, calculated and observed molecular weight with MS data, HPLC purity with method details and chromatogram image, and (for in vivo use) endotoxin testing results.

Evaluating CoAs critically is a learnable skill that directly improves research quality. For related quality topics, see our guides on Peptide Purity Testing Methods and Peptide Contamination & Purity.

---

All information is for laboratory research use only. Not for human consumption.

CoA Red Flags by Supplier Tier

When comparing suppliers on Peptides.SO, the CoA documentation quality is a reliable proxy for overall quality:

Top-Tier Supplier CoA Characteristics

Leading research peptide suppliers provide:

•Lot-specific CoA generated for each individual batch — not a shared template
•Full HPLC chromatogram image with integration table, method details, and system suitability information
•High-resolution MS data with isotope pattern confirmation or HRMS (within 5 ppm)
•Amino acid analysis providing true peptide content by mass
•Endotoxin data with specific EU/mg values (not just 'pass/fail')
•Water content by Karl Fischer titration
•Sterility testing for injectable-grade products
•Long-term stability data or shelf-life recommendations based on accelerated stability studies

Mid-Tier Supplier CoA Characteristics

Acceptable documentation for most research:

•Lot-specific HPLC purity with chromatogram image
•MS molecular weight confirmation
•Purity ≥98%
•Appearance description

Low-Tier or Concerning CoA Characteristics

Warrants caution or independent verification:

•Purity number without chromatogram
•Chromatogram without method details
•MS stated as 'confirmed' without m/z data
•Non-lot-specific or 'representative' CoA
•Very round purity numbers (exactly 98.00%, 99.00%) without decimal variation

Special Considerations for Specific Peptide Classes

GH-Axis Peptides (GHRPs, GHRHs)

GHRP-class peptides (GHRP-2, GHRP-6, Ipamorelin, CJC-1295) are widely studied. Key CoA considerations:

•These peptides are relatively small (1-3 kDa) and well-characterized; mass confirmation should be straightforward
•Common impurities include des-amino analogs, oxidized variants (if Met present)
•Ipamorelin contains no Met or Cys; oxidation impurities should be minimal

Cysteine-Containing Peptides

Peptides with Cys residues (e.g., some cyclic peptides with disulfide bonds) require careful CoA interpretation:

•Reduced vs. oxidized (disulfide) forms have different masses (Δ2.016 Da per disulfide bond)
•CoA should specify which form was analyzed
•If disulfide bonds are required for activity, MS should confirm the disulfide-bonded form

Large Peptides and Proteins (>40 AA)

For larger research peptides:

•High-resolution MS becomes more important — unit-resolution data may not distinguish closely-related impurities
•HPLC resolution of synthetic impurities is more challenging
•LC-MS (online coupling) is more informative than separate HPLC and MS analyses

Regulatory Context for CoA Requirements

For researchers working in regulated environments:

GLP (Good Laboratory Practice) studies: Require documented reagent quality with lot-specific data. CoA must be retained as part of study records.

GMP (Good Manufacturing Practice): Research peptides are not manufactured under GMP unless specifically intended for clinical use. Research CoAs do not meet GMP standards.

Institutional requirements: Many research institutions have internal policies requiring specific quality documentation for reagents used in federally funded research. Consult your institution's research compliance office.

Publication standards: Leading journals increasingly require disclosure of reagent sources and quality documentation. Maintaining comprehensive CoA records supports transparent methodology reporting.

Digital CoA Management

Best practices for managing CoAs in a research environment:

Electronic filing system:

•Create a folder structure: /Reagents/Peptides/[Supplier]/[Peptide]/[Lot Number]/
•Store: CoA PDF, purchase order, receipt confirmation, any independent test results
•Naming convention: Peptide_Supplier_LotNum_Date.pdf

Laboratory notebook integration:

•Record lot number in notebook for every experiment
•Note any anomalies observed with the product
•Cross-reference to electronic CoA file location

Group/institutional sharing:

•Share CoA archive within research group so all members can access quality documentation
•Use shared drive or laboratory management software (e.g., Benchling, LabArchives)

This documentation discipline pays dividends when auditing unexpected results, preparing publications, or responding to reviewer questions about reagent quality.

Frequently Asked Questions About Peptide CoAs

Q: Can I use a CoA from a previous lot if my current lot does not have one?

A: No. Each lot is a distinct production batch with its own characteristics. A previous lot CoA provides no quality assurance for the current lot. Always insist on lot-specific documentation.

Q: The supplier says the CoA is available 'upon request' — is this acceptable?

A: Reputable suppliers should provide CoA automatically with each order or make it immediately available online by lot number. 'Upon request' is a yellow flag; if the CoA is not pre-prepared, ask when it will be available before placing the order.

Q: What if the CoA shows 97.8% purity but I need 98%?

A: A CoA result of 97.8% means the batch did not meet the 98% specification. Whether to use it depends on your experimental needs. For dose-response studies, the ~2% impurity fraction may introduce variability. For initial feasibility studies, 97.8% is often acceptable. Do not simply round up and call it 98%.

Q: Should I store the CoA with the peptide vial?

A: It is helpful to keep a printed or labeled copy of the lot number with the stored peptide (on the vial label or storage box). Keep the full CoA document in your electronic records system for retrieval when needed.

Q: What makes Janoshik or Vanta test reports more credible than supplier-provided CoAs?

A: Janoshik, Vanta, and similar independent labs have no financial relationship with the peptide supplier — they charge a flat testing fee regardless of outcome. Their business model depends on accurate results, not satisfied sellers. Additionally, Janoshik reports are often posted publicly with verifiable report numbers, so the research community can confirm authenticity independently.

Q: How do I know if a supplier's "third-party tested" claim is genuine?

A: Look for a report number, lab name, and date — then verify the report directly on the lab's website if possible (Janoshik offers this). Be skeptical of vague claims like "independently tested" without a verifiable report. Our Suppliers directory flags which vendors provide verifiable third-party documentation.

Q: What is the difference between in-house and third-party CoAs?

A: An in-house CoA is produced by the supplier testing their own product — there is an inherent conflict of interest. A third-party CoA is produced by an independent lab with no stake in the results. Both can be legitimate, but third-party testing carries greater credibility because it removes the supplier's financial motivation to report favorable results.

For purchasing guidance and supplier CoA comparisons, see our Suppliers directory, Peptide Vendor Comparison Guide and Peptide Purity Testing Methods.

---

Further Reading: